Terms: = Lung cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393 AND Prognosis
12 results:
1. The Value of Combined Detection of Serum PSA, MALAT1 and tmprss2-ETV1 in Evaluating the Progress and prognosis of Prostate cancer.
Zhao G; Pan Z; Wang P
Arch Esp Urol; 2023 Oct; 76(8):555-562. PubMed ID: 37960954
[TBL] [Abstract] [Full Text] [Related]
2. ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19.
Pietzner M; Chua RL; Wheeler E; Jechow K; Willett JDS; Radbruch H; Trump S; Heidecker B; Zeberg H; Heppner FL; Eils R; Mall MA; Richards JB; Sander LE; Lehmann I; Lukassen S; Wareham NJ; Conrad C; Langenberg C
Nat Commun; 2022 Aug; 13(1):4484. PubMed ID: 35970849
[TBL] [Abstract] [Full Text] [Related]
3. Potential applications of prognostic and immunological marker transmembrane serine proteinase 2 in prediction, prevention and personalized treatment of lung cancer.
Mu B; Zhang R; Pu Y; Yao J; Hu X; Zhao C
Eur J Cancer Prev; 2023 Jan; 32(1):65-68. PubMed ID: 35170548
[TBL] [Abstract] [Full Text] [Related]
4. Decreased tmprss2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration.
Liu X; Liu B; Shang Y; Cao P; Hou J; Chen F; Zhang B; Fan Y; Tan K
Aging (Albany NY); 2022 Jan; 14(1):73-108. PubMed ID: 35017320
[TBL] [Abstract] [Full Text] [Related]
5. Multi-omics of the expression and clinical outcomes of tmprss2 in human various cancers: A potential therapeutic target for COVID-19.
Liu L; Qin JF; Zuo MZ; Zhou Q
J Cell Mol Med; 2022 Feb; 26(3):709-724. PubMed ID: 34951103
[TBL] [Abstract] [Full Text] [Related]
6.
Hu S; Hu Z; Qin J; Lin C; Jiang X
Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
[TBL] [Abstract] [Full Text] [Related]
7. Genetic Susceptibility of ACE2 and tmprss2 in Six Common cancers and Possible Impacts on COVID-19.
Hoang T; Nguyen TQ; Tran TTA
Cancer Res Treat; 2021 Jul; 53(3):650-656. PubMed ID: 33421977
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive analysis of two potential novel SARS-CoV-2 entries, tmprss2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection.
Kong Q; Xiang Z; Wu Y; Gu Y; Guo J; Geng F
Mol Cancer; 2020 Apr; 19(1):80. PubMed ID: 32345328
[TBL] [Abstract] [Full Text] [Related]
10. Weighted gene expression profiles identify diagnostic and prognostic genes for lung adenocarcinoma and squamous cell carcinoma.
Wu X; Wang L; Feng F; Tian S
J Int Med Res; 2020 Mar; 48(3):300060519893837. PubMed ID: 31854219
[TBL] [Abstract] [Full Text] [Related]
11. Potential Resistance Mechanisms Revealed by Targeted Sequencing from lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs).
Zhong J; Li L; Wang Z; Bai H; Gai F; Duan J; Zhao J; Zhuo M; Wang Y; Wang S; Zang W; Wu M; An T; Rao G; Zhu G; Wang J
J Thorac Oncol; 2017 Dec; 12(12):1766-1778. PubMed ID: 28818608
[TBL] [Abstract] [Full Text] [Related]
12. First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
Bokemeyer C; Schleucher N; Metzner B; Thomas M; Rick O; Schmoll HJ; Kollmannsberger C; Boehlke I; Kanz L; Hartmann JT
Br J Cancer; 2003 Jul; 89(1):29-35. PubMed ID: 12838296
[TBL] [Abstract] [Full Text] [Related]
